← peptides typeshit

Retatrutide cut albuminuria 49.2% vs placebo in the TRANSCEND-CKD trial

At ASN Kidney Week 2026, the phase 2b data showed lower kidney pressure and kidney fat at 24 weeks, but measured GFR did not change.

Read at HCPLive

Recap by typeshit. Full story at HCPLive.